Scientific challenges in developing biological markers for autism
نویسندگان
چکیده
منابع مشابه
Scientific challenges in developing biological markers for autism
Abstract Introduction Autism is a highly heterogeneous disorder, with a strong genetic basis and many associated medical and behavioural comorbidities. Current diagnostic methods and screening tools are somewhat subjective and are difficult to assess in younger children, which often results in missed opportunities for early intervention. A biological marker that could predict autism risk, assis...
متن کاملDeveloping Software for a Scientific Community: Some Challenges and Solutions
There are significant challenges in developing scientific software for a broad community. In this chapter, we discuss how these challenges are somewhat different both from those encountered when a scientist end-user developer develops software to address a very specific scientific problem of his/her own, and from those encountered in many commercial developments. However, many developers of sci...
متن کاملBiological challenges to effective vaccines in the developing world.
The reason for holding a meeting to discuss biological challenges to vaccines is simple: not all vaccines work equally well in all settings. This special issue reviews the performance of vaccines in challenging environments, summarizes current thinking on the reasons why vaccines underperform and considers what approaches are necessary to understand the heterogeneity in responses and to improve...
متن کاملScientific Authority in Health Sciences; Challenges and Solutions
Background: The perspective of scientific authority in Iran, by the year 1435, requires a growing strong generation with a sense of self-esteem, academic endeavor and responsible in today's competitive world. Strategic planning of human resources and education of youth with talent, commitment, vitality and hope requires a national will along with adequate resources. The aim of this study was to...
متن کاملDeveloping new pharmacotherapies for autism.
Developing new pharmacotherapies for autism spectrum disorder (ASD) is a challenge. ASD has a complex genetic architecture, several neurobiological phenotypes and multiple symptom domains. However, new opportunities are emerging that could lead to the development of 'targeted' and individualized pharmacological interventions. Here, first we review these important new insights into the aetiology...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: OA Autism
سال: 2013
ISSN: 2052-7810
DOI: 10.13172/2052-7810-1-1-474